Ensign Peak Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
41,723
+8,318
| +25% | +$2.61M | 0.02% | 409 |
|
|
2025
Q1 | $10.2M | Sell |
33,405
-17,043
| -34% | -$5.19M | 0.02% | 460 |
|
|
2024
Q4 | $16.8M | Buy |
50,448
+15,036
| +42% | +$5M | 0.03% | 345 |
|
|
2024
Q3 | $11.8M | Sell |
35,412
-411
| -1% | -$137K | 0.02% | 424 |
|
|
2024
Q2 | $14.8M | Buy |
35,823
+22,441
| +168% | +$9.24M | 0.03% | 367 |
|
|
2024
Q1 | $5.41M | Buy |
13,382
+4,467
| +50% | +$1.81M | 0.01% | 613 |
|
|
2023
Q4 | $2.73M | Buy |
8,915
+180
| +2% | +$55.2K | 0.01% | 798 |
|
|
2023
Q3 | $2.12M | Buy |
8,735
+265
| +3% | +$64.2K | ﹤0.01% | 822 |
|
|
2023
Q2 | $2.03M | Buy |
8,470
+1,490
| +21% | +$358K | ﹤0.01% | 871 |
|
|
2023
Q1 | $1.31M | Buy |
6,980
+150
| +2% | +$28.2K | ﹤0.01% | 1030 |
|
|
2022
Q4 | $1.45M | Sell |
6,830
-1,100
| -14% | -$234K | ﹤0.01% | 935 |
|
|
2022
Q3 | $1.25M | Sell |
7,930
-1,660
| -17% | -$261K | ﹤0.01% | 960 |
|
|
2022
Q2 | $1.44M | Hold |
9,590
| – | – | ﹤0.01% | 949 |
|
|
2022
Q1 | $1.57M | Sell |
9,590
-1,545
| -14% | -$253K | ﹤0.01% | 980 |
|
|
2021
Q4 | $2.42M | Sell |
11,135
-17,865
| -62% | -$3.89M | ﹤0.01% | 891 |
|
|
2021
Q3 | $5.49M | Hold |
29,000
| – | – | 0.01% | 619 |
|
|
2021
Q2 | $5.12M | Buy |
29,000
+6,100
| +27% | +$1.08M | 0.01% | 642 |
|
|
2021
Q1 | $3.76M | Hold |
22,900
| – | – | 0.01% | 758 |
|
|
2020
Q4 | $3.19M | Sell |
22,900
-600
| -3% | -$83.5K | 0.01% | 802 |
|
|
2020
Q3 | $2.63M | Hold |
23,500
| – | – | 0.01% | 829 |
|
|
2020
Q2 | $2.19M | Hold |
23,500
| – | – | 0.01% | 922 |
|
|
2020
Q1 | $1.72M | Hold |
23,500
| – | – | 0.01% | 913 |
|
|
2019
Q4 | $1.98M | Buy |
+23,500
| New | +$1.98M | 0.01% | 1066 |
|